Globus Medical
GMED
307 hedge funds and large institutions have $3.97B invested in Globus Medical in 2019 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 108 increasing their positions, 94 reducing their positions, and 19 closing their positions.
242% more first-time investments, than exits
New positions opened: 65 | Existing positions closed: 19
15% more repeat investments, than reductions
Existing positions increased: 108 | Existing positions reduced: 94
15% more funds holding
Funds holding: 268 → 307 (+39)
14% more capital invested
Capital invested by funds: $3.48B → $3.97B (+$489M)
1.27% less ownership
Funds ownership: 88.88% → 87.61% (-1.3%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
24% less call options, than puts
Call options by funds: $13.6M | Put options by funds: $17.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Axa
Paris,
France
|
+$24.1M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$20.8M |
| 3 |
Two Sigma Investments
New York
|
+$12.4M |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$12.2M |
| 5 |
BlackRock
New York
|
+$11.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ninety One (UK)
London,
United Kingdom
|
-$73.1M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$67.1M |
| 3 |
NI
Nuance Investments
Kansas City,
Missouri
|
-$40M |
| 4 |
Janus Henderson Group
London,
|
-$16.6M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$15.4M |
GMED Hedge Fund Activity: Q4 2019 in Review
307 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q4 2019, worth a combined $3.97B — up 14% from $3.48B a quarter earlier.
Buyers outnumbered sellers: 65 funds opened new GMED positions and 19 closed out — a net gain of 46 holders — while 108 added to existing stakes and 94 trimmed.
The largest buyer was Axa, adding an estimated $24.1M. The largest seller was Ninety One (UK), exiting entirely with an estimated $73.1M sold.
- 307 institutional investors held Globus Medical (GMED) as of Q4 2019, up from 268 in Q3 2019.
- Funds reported $3.97B of Globus Medical stock for Q4 2019, up 14% quarter-over-quarter.
- 65 funds opened new Globus Medical positions in Q4 2019 and 19 closed out, a net change of +46 holders.
- The largest Globus Medical buyer in Q4 2019 was Axa, an estimated $24.1M added.
- The largest Globus Medical seller in Q4 2019 was Ninety One (UK), an estimated $73.1M sold.
Based on aggregated 13F filings for Q4 2019.